1. Home
  2. CL vs ZTS Comparison

CL vs ZTS Comparison

Compare CL & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CL
  • ZTS
  • Stock Information
  • Founded
  • CL 1806
  • ZTS 1952
  • Country
  • CL United States
  • ZTS United States
  • Employees
  • CL N/A
  • ZTS N/A
  • Industry
  • CL Package Goods/Cosmetics
  • ZTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CL Consumer Discretionary
  • ZTS Health Care
  • Exchange
  • CL Nasdaq
  • ZTS Nasdaq
  • Market Cap
  • CL 73.0B
  • ZTS 66.2B
  • IPO Year
  • CL N/A
  • ZTS 2013
  • Fundamental
  • Price
  • CL $78.26
  • ZTS $121.27
  • Analyst Decision
  • CL Buy
  • ZTS Buy
  • Analyst Count
  • CL 15
  • ZTS 9
  • Target Price
  • CL $91.07
  • ZTS $182.22
  • AVG Volume (30 Days)
  • CL 7.6M
  • ZTS 4.2M
  • Earning Date
  • CL 10-31-2025
  • ZTS 11-04-2025
  • Dividend Yield
  • CL 2.66%
  • ZTS 1.66%
  • EPS Growth
  • CL 2.56
  • ZTS 11.64
  • EPS
  • CL 3.57
  • ZTS 5.94
  • Revenue
  • CL $20,097,000,000.00
  • ZTS $9,397,000,000.00
  • Revenue This Year
  • CL $4.06
  • ZTS $3.84
  • Revenue Next Year
  • CL $3.74
  • ZTS $5.89
  • P/E Ratio
  • CL $21.86
  • ZTS $20.35
  • Revenue Growth
  • CL N/A
  • ZTS 2.68
  • 52 Week Low
  • CL $74.55
  • ZTS $117.26
  • 52 Week High
  • CL $100.18
  • ZTS $181.85
  • Technical
  • Relative Strength Index (RSI)
  • CL 49.09
  • ZTS 21.61
  • Support Level
  • CL $77.92
  • ZTS $117.26
  • Resistance Level
  • CL $79.74
  • ZTS $122.96
  • Average True Range (ATR)
  • CL 1.46
  • ZTS 2.88
  • MACD
  • CL 0.31
  • ZTS -1.43
  • Stochastic Oscillator
  • CL 68.24
  • ZTS 11.82

About CL Colgate-Palmolive Company

Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: